Matches in UGent Biblio for { <https://biblio.ugent.be/publication/357934#aggregation> ?p ?o. }
Showing items 1 to 31 of
31
with 100 items per page.
- aggregation classification "A1".
- aggregation creator person.
- aggregation date "2006".
- aggregation format "application/pdf".
- aggregation hasFormat 357934.bibtex.
- aggregation hasFormat 357934.csv.
- aggregation hasFormat 357934.dc.
- aggregation hasFormat 357934.didl.
- aggregation hasFormat 357934.doc.
- aggregation hasFormat 357934.json.
- aggregation hasFormat 357934.mets.
- aggregation hasFormat 357934.mods.
- aggregation hasFormat 357934.rdf.
- aggregation hasFormat 357934.ris.
- aggregation hasFormat 357934.txt.
- aggregation hasFormat 357934.xls.
- aggregation hasFormat 357934.yaml.
- aggregation isPartOf urn:issn:0300-9009.
- aggregation language "eng".
- aggregation rights "I have transferred the copyright for this publication to the publisher".
- aggregation subject "Medicine and Health Sciences".
- aggregation title "The relevance of monitoring lamotrigine serum concentrations in chronic pain patients".
- aggregation abstract "Lamotrigine is a novel anticonvulsant initially used in epilepsy treatment. Because of its physiological properties it has subsequently been introduced in pain management and has become an interesting co-analgesic, because it inhibits release of excitatory neurotransmitters, influences different sodium, calcium en potassium channels and elevates the GABA levels. A linear relationship appears to exist between serum concentrations, drug activity and clinical outcome. However: measurement of lamotrigine serum concentrations is very useful for daily dose adjustments in order to prevent toxic reactions. In most studies describing the neuropathic pain-relieving effects of lamotrigine, a daily oral dose of 300 to 400 mg was administered. Some of our patients received 800 mg lamotrigine with better results than when 400 mg doses were used. The serum concentrations in these patients were higher but still below the so-called dangerous level of approximately 15 mg/L. Lamotrigine itself is metabolized by conjugation to form inactive metabolites. Lamotrigine serum concentrations can be influenced by the intake of other drugs metabolized by the cytrochrome P450. As good pain relief depends on adequate lamotrigine serum concentrations and dangerous side effects should be avoided, we recommend to monitor individual concentration levels in relation to lamotrigine dosage. However skin rash is an important adverse effect of lamotrigine and is independent from plasma concentration levels.".
- aggregation authorList BK495798.
- aggregation endPage "18".
- aggregation issue "1".
- aggregation startPage "15".
- aggregation volume "106".
- aggregation aggregates 572607.
- aggregation isDescribedBy 357934.
- aggregation similarTo LU-357934.